AUTM Newsbrief
Dec. 12, 2013

House Passes Innovation Act; Battle Goes to Senate
On Dec. 5, the United States House of Representatives passed the Innovation Act by a vote of 325-91. Surprisingly, the Innovation Act (H.R. 3309) had only been introduced on Oct. 23, and was marked up on Nov. 20. So what was the rush? This breakneck pace, which took place in a Congress that has been noted for its extraordinary inaction, is curious to say the least. Indeed, one member of Congress went much further than raising a curious eyebrow.More

Virginia Commonwealth Advocating Entrepreneurship
Richmond Times-Dispatch
When David Simpson, Ph.D., arrived at Virginia Commonwealth University in 1996, the university's technology transfer office suggested he meet Gary Bowlin, Ph.D., a biomedical engineer. Simpson's research focused on cell biology. Bowlin was a tissue engineer studying ways to grow new tissue. The two became prolific, filing 75 invention disclosures. And now VCU's tech transfer office is rebranding itself as the VCU Innovation Gateway, part of a universitywide push to emphasize entrepreneurship and innovation while creating jobs for the region. More

IU Dental School to Help Homeless Veterans
In a program started by longtime AUTM member Jude Wilkinson, the IU School of Dentistry will help unemployed homeless veterans in Indianapolis overcome a barrier that often stands in the way of a job. School faculty, assisted by dental students, will make the veterans more employable by giving them the kind of dental appearance needed for jobs in the public eye, said Karen Yoder, director of civic engagement and health policy and a professor of preventive and community dentistry. More

University of Florida 3-D Modeling Startup Lands $300K from State Commercialization Program
Mind the Gap
Gainesville, Fla.-based Paracosm has secured $800,000 in private and public funding to advance its 3-D modeling and navigation software. The funding includes $300,000 from the Institute for the Commercialization of Public Research. The institute, which has an office in the University of Florida Innovation Hub, funds and mentors companies that spin out of state university research and private research institutions.More

Duquesne University Enters Largest Licensing Deal for Cancer
Treatment Drugs

Pittsburgh Business Times
Nearly 50 patents, developed quietly in the labs of Duquesne University, could hold big potential for the treatment of cancer. Working with Flag Therapeutics Inc., a Raleigh, N.C.-based startup run by Duquesne alum Frank Sorgi, the university has entered into a licensing agreement for two novel classes of duel-acting, water-soluble drugs developed for the treatment of cancer.More

Texas Tech Receives Federal Grant to Facilitate Technology Transfer
Texas Tech has announced the receipt of a $300,000 federal grant. The Economic Development Administration, an agency within the United States Department of Commerce, awarded the grant to Texas Tech University to help build on the South Plains region's capability in wind and other renewable energy sources that increase innovation and entrepreneurship through technology commercialization.More

Cellular Switches: Tech Transfer from the Dirt
Researchers in New Zealand recently published research of a new genome technological breakthrough that isolates the genetic markers that tell an onion when to grow a bulb. This is vital, because plant geneticists can now develop onions that adjust to soil type and growing conditions. Scientists at the University of Otago discovered the molecular mechanism that functions on organic electricity.More

MedStar Hopes Patent Deal Spurs Tech Transfer Efforts
Baltimore Business Journal
MedStar Health hopes its patent deal with a Beltsville medical device company is just the beginning. Columbia, Md.-based MedStar Health will look to grow its commercialization program, called the MedStar Institute for Innovation, in the coming years as a way to improve its patient treatment methods and bring in new revenue. More

University of Utah Licenses Omicia's Opal for Genomic Interpretation
Omicia and the University of Utah said that they have signed a two-year licensing agreement that allows researchers involved in the Utah Genome Project use Opal, Omicia's platform for analyzing genomics in research and clinical applications, to analyze disease causing variants. More

AUTM 2014 Annual Meeting: Early Registration Deadline Dec. 18
There is so much to do at the AUTM Annual Meeting. Between partnering meetings, networking events, sessions, mini courses and fun activities, the hardest part about the meeting is deciding how to spend your time.

First things first, if you haven't yet registered, do that now. If you register by Dec. 18, you'll save $75! Second, maximize your time by choosing sessions that are right for you. To make this easy, check out our session picker, which allows you to filter sessions by track or experience level. Find workshops that are right for you. More

Expand Your Reach at the AUTM Annual Meeting
Make a statement at the AUTM 2014 Annual Meeting as an exhibitor or sponsor — each an affordable way to reinforce your brand or introduce your company to the largest in-person gathering of academic technology transfer professionals.More

AUTM 40th Anniversary Celebration
AUTM celebrates its 40th anniversary in 2014 and will kick off the yearlong celebration at the AUTM 2014 Annual Meeting. While there will be some nods to the past, the celebration will be very forward thinking, and AUTM needs YOUR help!More

Veteran Entrepreneur Explores New Way of Giving Back to UCLA
Upstart Business Journal
Think of the California university most closely tied to entrepreneurship, and Stanford immediately leaps to mind, or maybe the University of California at Berkeley. Michael Silton is looking to add UCLA to that list, and he's come up with a unique way of funding that effort.More

CDRD to Tackle Bladder Cancer
Global University Venturing
The Centre for Drug Research and Development has launched Sitka Biopharma, a spinout looking to commercialize bladder cancer treatment. The new company was launched through the CDRD's tech transfer unit, CDRD Ventures, and utilizes research emerged through a collaboration between the organization and the University of British Columbia.More

We Need Patent Reform, Not Patent Deform!
American Innovators for
Patent Reform

We Americans have a love-hate relationship with patents. We can't live with them, and we can't live without them. Everybody wants to reform the patent system. After many years of contentious debate, in 2011, the America Invents Act was signed into law. Alas, this act did not help America to invent anything — nor was it ever intended to do that.More

AUTM Membership Renewal
It's time to reiterate your commitment to lifelong learning and confirm your affiliation with the world's premier academic technology transfer community by renewing your AUTM membership for 2014. If you're planning to attend the AUTM 2014 Annual Meeting, Feb. 19-22, in San Francisco, CA, your membership discount for this meeting alone will more than offset the cost of your membership. There are plenty of other membership features and benefits, too. Read about them here.

For more information, contact AUTM headquarters at or 1-847-559-0846.More

AUTM Royalty and Deals Database Needs YOUR Deals
AUTM has launched the data collection phase for the new AUTM Royalty and Deals Database, a powerful comprehensive database of transactional terms and conditions that only AUTM could amass.

We need your deals!
AUTM directors were sent login instructions in November. If you will be responsible for entering deals for your institution and you did not receive an email with your login and a link to the database, contact and Chrys Gwellem at AUTM headquarters: or 1-847-559-0846, Ext. 360.

To make the Royalty and Deals Database as successful and meaningful as possible, please visit the database and enter your deals as soon as possible. As an incentive to provide content, your institution will receive a discount on the subscription price of the Royalty and Deals Database based on the number deals contributed. The exact pricing model is still being developed.

Types of Deals to Enter
While we are interested in a broad spectrum of license agreements (e.g., exclusive as well as nonexclusive) covering a range of industry sectors (e.g., biomedical, nanotechnology, etc.), we are particularly interested in deals that contain a variety of business terms (e.g., upfront payments, milestones, equity, etc.). More